146 related articles for article (PubMed ID: 17300638)
1. Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo.
Robays J; Lefèvre P; Lutumba P; Lubanza S; Kande Betu Ku Mesu V; Van der Stuyft P; Boelaert M
Trop Med Int Health; 2007 Feb; 12(2):290-8. PubMed ID: 17300638
[TBL] [Abstract][Full Text] [Related]
2. From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.
Mpanya A; Hendrickx D; Baloji S; Lumbala C; da Luz RI; Boelaert M; Lutumba P
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003686. PubMed ID: 25856578
[TBL] [Abstract][Full Text] [Related]
3. Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo.
Hasker E; Lumbala C; Mbo F; Mpanya A; Kande V; Lutumba P; Boelaert M
Trop Med Int Health; 2011 Jul; 16(7):869-74. PubMed ID: 21447063
[TBL] [Abstract][Full Text] [Related]
4. Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.
Mpanya A; Hendrickx D; Vuna M; Kanyinda A; Lumbala C; Tshilombo V; Mitashi P; Luboya O; Kande V; Boelaert M; Lefèvre P; Lutumba P
PLoS Negl Trop Dis; 2012 Jan; 6(1):e1467. PubMed ID: 22272367
[TBL] [Abstract][Full Text] [Related]
5. In the heart of darkness: sleeping sickness in Zaire.
Ekwanzala M; Pépin J; Khonde N; Molisho S; Bruneel H; De Wals P
Lancet; 1996 Nov; 348(9039):1427-30. PubMed ID: 8937285
[TBL] [Abstract][Full Text] [Related]
6. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
[TBL] [Abstract][Full Text] [Related]
7. Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.
Lutumba P; Robays J; Miaka mia Bilenge C; Mesu VK; Molisho D; Declercq J; Van der Veken W; Meheus F; Jannin J; Boelaert M
Emerg Infect Dis; 2005 Sep; 11(9):1382-8. PubMed ID: 16229766
[TBL] [Abstract][Full Text] [Related]
8. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo.
Robays J; Bilengue MM; Van der Stuyft P; Boelaert M
Trop Med Int Health; 2004 May; 9(5):542-50. PubMed ID: 15117297
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological, clinical and sociodemographic characteristics of human African trypanosomiasis (HAT) in and around Kinshasa, Democratic Republic of Congo].
Tshimungu K; Okenge LN; Mukeba JN; Kande VB; De Mol P
Sante; 2009; 19(2):73-80. PubMed ID: 20031514
[TBL] [Abstract][Full Text] [Related]
11. Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo.
Snijders R; Fukinsia A; Claeys Y; Mpanya A; Hasker E; Meheus F; Miaka E; Boelaert M
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008832. PubMed ID: 33315896
[TBL] [Abstract][Full Text] [Related]
12. Human African trypanosomiasis in a rural community, Democratic Republic of Congo.
Lutumba P; Makieya E; Shaw A; Meheus F; Boelaert M
Emerg Infect Dis; 2007 Feb; 13(2):248-54. PubMed ID: 17479887
[TBL] [Abstract][Full Text] [Related]
13. Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020.
Bemba I; Bamou R; Lenga A; Okoko A; Awono-Ambene P; Antonio-Nkondjio C
J Med Entomol; 2022 Mar; 59(2):421-429. PubMed ID: 35137146
[TBL] [Abstract][Full Text] [Related]
14. Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo.
Rock KS; Torr SJ; Lumbala C; Keeling MJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005162. PubMed ID: 28056016
[TBL] [Abstract][Full Text] [Related]
15. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
Mpandzou G; Cespuglio R; Ngampo S; Bandzouzi B; Bouteille B; Vincendeau P; Buguet A
J Neurol Sci; 2011 Jun; 305(1-2):112-5. PubMed ID: 21470639
[TBL] [Abstract][Full Text] [Related]
16. [Re-emergence of human African trypanosomiasis in Kinshasa, Democratic Republic of Congo (DRC)].
Tshimungu K; Okenge LN; Mukeba JN; de Mol P
Med Mal Infect; 2010 Aug; 40(8):462-7. PubMed ID: 20079989
[TBL] [Abstract][Full Text] [Related]
17. Human African trypanosomiasis (HAT) in the Republic of Congo: why the Congolese population is reluctant to screening?
Elenga VA; Lissom A; Vouvoungui C; Tsengue-Tsengue ; Ahombo G; Ntoumi F
Pan Afr Med J; 2022; 42():309. PubMed ID: 36425545
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo.
Mumba D; Bohorquez E; Messina J; Kande V; Taylor SM; Tshefu AK; Muwonga J; Kashamuka MM; Emch M; Tidwell R; Büscher P; Meshnick SR
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1246. PubMed ID: 21829736
[TBL] [Abstract][Full Text] [Related]
19. Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.
Das AM; Chitnis N; Burri C; Paris DH; Patel S; Spencer SEF; Miaka EM; Castaño MS
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009992. PubMed ID: 34843475
[TBL] [Abstract][Full Text] [Related]
20. High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo.
Robays J; Nyamowala G; Sese C; Betu Ku Mesu Kande V; Lutumba P; Van der Veken W; Boelaert M
Emerg Infect Dis; 2008 Jun; 14(6):966-7. PubMed ID: 18507916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
